How should I manage a patient with a hypertensive headache, including assessment for hypertensive urgency versus emergency and appropriate acute treatment?

Management of Hypertensive Headache

A patient presenting with headache and elevated blood pressure requires immediate assessment for acute target-organ damage to distinguish hypertensive emergency (requiring ICU admission and IV therapy) from hypertensive urgency (managed outpatient with oral agents)—the presence or absence of organ injury, not the blood pressure number itself, determines management. 1, 2

Immediate Assessment for Target-Organ Damage

Perform a rapid, focused evaluation within minutes to identify acute organ injury:

Neurologic Assessment

• Altered mental status, seizures, severe headache with vomiting, visual disturbances, or focal neurologic deficits suggest hypertensive encephalopathy or stroke 1, 2
• Somnolence or lethargy may precede seizures and coma in hypertensive encephalopathy 1
• The rate of blood pressure rise is often more important than the absolute value 1

Cardiac Assessment

• Chest pain or dyspnea with pulmonary edema indicates possible acute coronary syndrome, aortic dissection, or acute left ventricular failure 1, 2

Ophthalmologic Assessment

• Fundoscopy looking for bilateral retinal hemorrhages, cotton-wool spots, or papilledema (grade III-IV retinopathy) defines malignant hypertension 1, 2
• Isolated subconjunctival hemorrhage is NOT acute target-organ damage 1

Laboratory Evaluation

• Complete blood count, basic metabolic panel, lactate dehydrogenase, haptoglobin, urinalysis, troponin, and ECG to assess for thrombotic microangiopathy, acute kidney injury, and cardiac injury 1, 2

---

If Target-Organ Damage is Present: Hypertensive Emergency

ICU Admission and Monitoring

• Admit immediately to ICU with continuous arterial-line blood pressure monitoring (Class I recommendation, Level B-NR) 1, 2
• Without treatment, 1-year mortality exceeds 79% with median survival of only 10.4 months 1

Blood Pressure Reduction Targets

Standard approach for most emergencies:

• Reduce mean arterial pressure by 20-25% (or systolic by ≤25%) within the first hour 1, 2
• Then reduce to ≤160/100 mmHg over the next 2-6 hours if stable 1, 2
• Gradually normalize over 24-48 hours 1, 2
• Avoid systolic drops >70 mmHg, which can precipitate cerebral, renal, or coronary ischemia, especially in chronic hypertensives with altered autoregulation 1, 2

Compelling condition-specific targets:

• Aortic dissection: SBP <120 mmHg within 20 minutes 1
• Acute coronary syndrome or pulmonary edema: SBP <140 mmHg immediately 1
• Eclampsia/severe preeclampsia: SBP <140 mmHg within first hour 1

First-Line IV Medications

Nicardipine (preferred for most emergencies except acute heart failure):

• Start at 5 mg/hr IV infusion 1, 3
• Increase by 2.5 mg/hr every 15 minutes until target blood pressure is reached (maximum 15 mg/hr) 1, 3
• Onset 5-15 minutes; duration 30-40 minutes 1
• Preserves cerebral blood flow and does not increase intracranial pressure 1, 2
• Change infusion site every 12 hours if administered via peripheral vein 3
• Must be diluted to 0.1 mg/mL concentration before infusion 3

Labetalol (preferred for aortic dissection, eclampsia, malignant hypertension with renal involvement):

• 10-20 mg IV bolus over 1-2 minutes, repeat or double every 10 minutes (maximum cumulative dose 300 mg) 1, 2
• Alternative: continuous infusion 2-8 mg/min 1, 2
• Contraindicated in reactive airway disease, COPD, heart block, bradycardia, and decompensated heart failure 1, 2

Condition-specific regimens:

• Acute coronary syndrome/pulmonary edema: IV nitroglycerin 5-100 µg/min ± labetalol; avoid nicardipine monotherapy due to reflex tachycardia 1, 2
• Aortic dissection: Esmolol loading 500-1000 µg/kg, then 50-200 µg/kg/min before any vasodilator (nitroprusside or nitroglycerin) to prevent reflex tachycardia 1, 2
• Eclampsia/preeclampsia: Labetalol, hydralazine, or nicardipine; ACE inhibitors, ARBs, and nitroprusside are absolutely contraindicated 1, 2
• Hypertensive encephalopathy: Nicardipine is superior as it preserves cerebral blood flow 1, 2

---

If NO Target-Organ Damage: Hypertensive Urgency

Outpatient Management

• Manage with oral medications and outpatient follow-up within 2-4 weeks; hospitalization is NOT required 1, 2
• Reduce blood pressure gradually over 24-48 hours to <160/100 mmHg 1, 2
• Avoid rapid blood pressure lowering, which may cause cerebral, renal, or coronary ischemia in chronic hypertensives 1, 2
• Up to one-third of patients with diastolic BP >95 mmHg normalize before follow-up 1, 2

Preferred Oral Agents

Captopril (ACE inhibitor):

• 12.5-25 mg PO 1, 4
• Caution in volume-depleted patients due to risk of sudden blood pressure drops 1, 4
• Should be taken one hour before meals 4

Extended-release nifedipine (calcium channel blocker):

• 30-60 mg PO 1, 2
• Never use immediate-release nifedipine due to unpredictable precipitous drops, stroke, and death 1, 2

Labetalol (oral):

• 200-400 mg PO 1, 2
• Contraindicated in reactive airway disease, heart block, bradycardia 1, 2

Follow-Up

• Outpatient visit within 2-4 weeks to reassess blood pressure 1, 2
• Target blood pressure <130/80 mmHg (or <140/90 mmHg in elderly/frail) within 3 months 1

---

Post-Stabilization Management

Screen for Secondary Causes

• 20-40% of malignant hypertension cases have identifiable secondary causes including renal artery stenosis, pheochromocytoma, primary aldosteronism, and renal parenchymal disease 1, 2

Long-Term Follow-Up

• Monthly visits until target blood pressure <130/80 mmHg is achieved and organ damage regresses 1, 2
• Address medication non-adherence, the most common trigger for hypertensive emergencies 1, 2
• Transition to oral regimen combining a renin-angiotensin system blocker, calcium channel blocker, and diuretic 1

---

Critical Pitfalls to Avoid

• Do not admit asymptomatic severe hypertension without target-organ damage—this is urgency, not emergency 1, 2
• Do not use oral agents for hypertensive emergencies—IV therapy is mandatory 1, 2
• Do not use immediate-release nifedipine—risk of precipitous drops, stroke, and death 1, 2
• Do not rapidly lower blood pressure in hypertensive urgency—gradual reduction is essential 1, 2
• Do not normalize blood pressure acutely in chronic hypertensives—altered autoregulation predisposes to ischemic injury 1, 2
• Do not use sodium nitroprusside except as last resort due to cyanide toxicity risk 1, 2